Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03967093
Title A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors
Acronym KOURAGE
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.